Limor Rubin Selected Research

Integrins

12/2021

Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Limor Rubin Research Topics

Disease

5	COVID-19 01/2023 - 01/2022
3	Inflammation (Inflammations) 01/2024 - 01/2022
3	Hypersensitivity (Allergy) 10/2023 - 03/2022
2	Lung Diseases (Lung Disease) 01/2024 - 01/2021
2	Atopic Dermatitis (Atopic Eczema) 08/2023 - 01/2022
2	Exanthema (Rash) 04/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2022
1	Anaphylaxis (Anaphylactic Shock) 10/2023
1	Pruritus (Itching) 08/2023
1	Neoplasms (Cancer) 08/2023
1	Multiple Myeloma 04/2023
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 04/2023
1	Drug Hypersensitivity Syndrome 01/2023
1	Solar Urticaria 01/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Hemorrhage 01/2023
1	Infections 01/2023
1	Common Variable Immunodeficiency 03/2022
1	Eczema 01/2022
1	Chronic Mucocutaneous Candidiasis 01/2022
1	Job Syndrome (Hyper-IgE Syndrome) 01/2022
1	Ischemic Stroke 01/2022
1	Cytokine Release Syndrome 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Abscess 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Epilepsy (Aura) 01/2022
1	Eosinophilia 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2021
1	Multiple Sclerosis 12/2021
1	Severe Acute Respiratory Syndrome 10/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 01/2023 - 10/2021
2	CytokinesIBA 08/2023 - 01/2022
2	dupilumabIBA 08/2023 - 01/2022
2	Immunoglobulin E (IgE)IBA 03/2022 - 01/2022
1	AMP-Activated Protein KinasesIBA 01/2024
1	EnzymesIBA 01/2024
1	Adenosine (Adenocard)FDA LinkGeneric 01/2024
1	PowdersIBA 10/2023
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2023
1	Interleukin-4 (Interleukin 4)IBA 08/2023
1	Interleukin-13IBA 08/2023
1	Thalidomide (Thalomid)FDA Link 04/2023
1	Lenalidomide (CC 5013)FDA Link 04/2023
1	benralizumabIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	AllergensIBA 01/2023
1	Excipients (Suspending Agents)IBA 01/2023
1	Histamine Antagonists (Antihistamines)IBA 01/2023
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2023
1	Interleukin-5 (Interleukin 5)IBA 01/2023
1	ligelizumabIBA 01/2023
1	Immunomodulating AgentsIBA 12/2022
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Immunoglobulins (Immunoglobulin)IBA 03/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	SteroidsIBA 01/2022
1	FibromodulinIBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	IntegrinsIBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	Natalizumab (Tysabri)FDA Link 12/2021
1	Therapeutic UsesIBA 12/2021
1	Cyclic PeptidesIBA 12/2021
1	SolutionsIBA 10/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021

Therapy/Procedure

5	Therapeutics 01/2024 - 12/2021
1	Emergency Treatment 10/2023
1	Contraindications 04/2023
1	Biological Therapy 01/2022
1	Genomic Medicine 01/2022
1	Phototherapy (Light Therapy) 01/2022
1	Immunotherapy 12/2021